- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Visiplex moves in with AFP Imaging
Visiplex Instruments has lostits lease, but don't expect the firm to hold a fire sale of compactcameras and picture archiving and communications systems. Instead,the firm is moving into the digs of its neighbor, AFP Imaging. Visiplex was formed last
Visiplex Instruments has lostits lease, but don't expect the firm to hold a fire sale of compactcameras and picture archiving and communications systems. Instead,the firm is moving into the digs of its neighbor, AFP Imaging.
Visiplex was formed last year when Agfa sold its Orangeburg,NY-based compact camera business to a management-led group (SCAN7/14/93). The firm branched into digital imaging by purchasingthe assets of Florida PACS developer Genesys (SCAN 8/10/94).
Agfa retained ownership of the building where Visiplex waslocated, however. Earlier this year Agfa informed Visiplex itintended to sell the property and wanted the building empty, accordingto Seamus Carroll, vice president of sales and marketing at Visiplex.
AFP Imaging had extra space available in its facility in nearbyElmsford, so the companies signed a long-term lease agreement,Carroll told SCAN. The firms have no connection other than thelandlord-tenant relationship, he added.
"Officially there is no formal relationship between thecompanies," Carroll said. "We will probably do somethings to be efficient and cost-conscious. We will be sharingsome space at the RSNA, for example. Wherever we can help eachother share costs we will do it."
Visiplex's new address is 250 Clearbrook Road, Elmsford, NY10523.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
